diff --git a/pages/STOP2030___Web.md b/pages/STOP2030___Web.md
index 41dacae3..1f87a9af 100644
--- a/pages/STOP2030___Web.md
+++ b/pages/STOP2030___Web.md
@@ -18,7 +18,7 @@
 			- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
 			- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in Sub-Saharan Africa
 		- FDC of ivm/alb has the lowest level of investment risk of all candidates for Combination for STH treatment (STH Drug Combinations Expert Meeting, BMGF, April 2016)
-		-
+		- Main results of previous STOP projects: ALIVE pivotal Trial
 		- Investigadores principales de cada uno de los partners
 		- Timeline y milestones (cuáles se han cumplido?)
 			- __Proposed safety and effectiveness study__